Table 2.
PEDro classification: methodological quality.
| Author | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bekkers et al. [25] | N | Y | N | Y | N | N | Y | Y | N | Y | Y | 6/10 |
| Del Din et al. [26] | N | Y | N | Y | N | N | N | N | Y | Y | Y | 5/10 |
| Feng et al. [27] | Y | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7/10 |
| Ferraz et al. [17] | Y | Y | Y | Y | N | N | Y | Y | N | Y | Y | 7/10 |
| Gandolfi et al. [28] | Y | Y | N | Y | N | N | Y | Y | N | Y | Y | 6/10 |
| van den Heuvel et al. [29] | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 8/10 |
| van der Kolk et al. [30] | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 7/10 |
| Liao et al. [31] | Y | Y | Y | Y | N | N | Y | Y | N | Y | Y | 7/10 |
| Liao et al. [32] | Y | Y | Y | Y | N | N | Y | Y | N | Y | Y | 7/10 |
| Ma et al. [33] | N | Y | Y | Y | N | N | N | N | N | Y | Y | 5/10 |
| Maidan et al. [34] | N | Y | N | Y | N | N | Y | N | N | Y | N | 4/10 |
| Maidan et al. [16] | Y | Y | N | Y | N | N | Y | N | N | Y | N | 4/10 |
| Mirelman et al. [35] | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 8/10 |
| Pelosin et al. [36] | N | Y | N | Y | N | N | Y | N | N | Y | N | 4/10 |
| Pompeu et al. [37] | N | Y | N | Y | N | N | Y | N | N | Y | Y | 5/10 |
| Shih et al. [38] | Y | Y | Y | Y | N | N | N | Y | N | Y | Y | 6/10 |
| Yang et al. [39] | Y | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7/10 |
| Yen et al. [40] | N | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7/10 |
Y = yes; 1. Eligibility criteria; 2. random distribution of subjects in each group; 3. secret allocation of subjects; 4. similar groups regarding the most important prognosis; 5. blind participation of subjects; 6. Blind participation of therapists; 7. blind examiners; 8. at least one key result obtained in more than 85% of subjects; 9. subjects received treatment or control condition; 10. intergroup statistical comparisons have been performed for at least one key outcome; 11. presence of precision and variability measures.